NZ506251A - Benzothiadiazine and benzothiadiazepine derivatives and their use as positive AMPA receptor modulators - Google Patents
Benzothiadiazine and benzothiadiazepine derivatives and their use as positive AMPA receptor modulatorsInfo
- Publication number
- NZ506251A NZ506251A NZ506251A NZ50625199A NZ506251A NZ 506251 A NZ506251 A NZ 506251A NZ 506251 A NZ506251 A NZ 506251A NZ 50625199 A NZ50625199 A NZ 50625199A NZ 506251 A NZ506251 A NZ 506251A
- Authority
- NZ
- New Zealand
- Prior art keywords
- alkyl
- optionally substituted
- aryl
- halogen
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
- C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
- C07D285/28—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Abstract
The compound of the formula shown, where: X is SO2; Y is CH(R4), N(R4), N(R4)-CH2 or O; R2 is H R3 is H, cycloalkyl, alkyl, cycloalkylalkyl, haloalkyl, hydroxyalkyl, cyanoalkyl, alkoxyalkyl, alkoxy, haloalkoxy, -alkyl-NR13R14, -alkyl-S-R13, an optionally substituted carbocyclic 7- to 12- membered ring, an optionally substituted heterocyclic 3- to 8- membered ring (optionally fused to an aryl), optionally substituted benzyl; or R3 and R4 together with the atoms to which they are attached form an optionally substituted 4- to 7- membered ring that optionally contains heteroatoms and carbonyl groups. R4 is H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, -CO-R10, or CO2R10; R5 is H, halogen, alkyl, alkenyl, alkynyl, aryl, or -SO2-NR11R12; R6 is H, halogen, alkyl, cyano, cyanoalkyl, nitro, alkoxy, haloalkoxy, hydroxyalkyl, cycloalkyl, cyclohaloalkyl, -NR15R16, -NHSO2-R15, -NHSO2-aryl, optionally substituted aryl, optionally substituted heterocyclic, -(alkyl)m-S-R15, -(alkyl)m-SO-R15, -(alkyl)m-SO2-R15, -(alkyl)m-SO2OR15, -(alkyl)m-SO2-NR15R16, -(alkyl)m-NHCOR15, -(alkyl)m-CONR15R16, -(alkyl)m-CR'=NOR", -(alkyl)m-CO-R15, or -(alkyl)m-CO2-R15; R7 is halogen, alkyl, cyano, cyanoalkyl, nitroalkyl, alkoxy, haloalkoxy, haloalkyl, hydroalkyl, cycloalkyl, cyclohaloalkyl, -NR17R18, -NHSO2-R17, -NHSO2-aryl, (alkyl)m-S-R17, -(alkyl)m-SO-R17, -(alkyl)m-SO2-R17, -(alkyl)m-SO2OR17, -(alkyl)mNHCOR17, -(alkyl)mCONR17R18, -(alkyl)m-CR'=NOR", -(alkyl)m-CO-R17, -(alkyl)mCO2-R17, -(alkyl)m-SO2-NR17R18, optionally substituted aryl, or optionally substituted heterocyclic; or R7 together with R6, or together with R8, forms a 5- to 7- membered ring; R8 is H, alkyl, alkoxy, hydroxyalkyl, halogen, haloalkyl, cyano, cyanoalkyl, nitro, nitroalkyl, optionally substituted aryl, optionally substituted heterocyclic, -(alkyl)m-S-R19, -(alkyl)m-SO-R19, -(alkyl)m-SO2-R19, -(alkyl)m-SO2OR19, -(alkyl)m-SO2-NR19R20, -(alkyl)mNHCOR19, -(alkyl)mCONR19R20, (alkyl)m-CR'=NOR", -(alkyl)m-CO-R19, or (alkyl)m-CO2-R19; The following proviso applies to the compounds described above: If one of R5, R6, R7, and R8 is halogen or alkyl or alkoxy, then one or more of the remainder of R5, R6, R7, and R8 is/are not halogen or alkyl, and then one or more of the remainder of R5, R6, R7, and R8 is/are not hydrogen. Also described are pharmaceutical compositions comprising the compound described above. The compounds described above are useful for the treatment of diseases and disorders that are responsive to the modulation of the AMPA receptor complex of the central nervous system.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK22698 | 1998-02-18 | ||
PCT/DK1999/000070 WO1999042456A2 (en) | 1998-02-18 | 1999-02-18 | Novel compounds and their use as positive ampa receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ506251A true NZ506251A (en) | 2003-01-31 |
Family
ID=8091151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ506251A NZ506251A (en) | 1998-02-18 | 1999-02-18 | Benzothiadiazine and benzothiadiazepine derivatives and their use as positive AMPA receptor modulators |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1071426A2 (en) |
JP (1) | JP2002504481A (en) |
CN (1) | CN1293665A (en) |
AU (1) | AU751384B2 (en) |
CA (1) | CA2320354A1 (en) |
EE (1) | EE200000468A (en) |
HU (1) | HUP0101280A3 (en) |
IL (1) | IL137720A0 (en) |
IS (1) | IS5581A (en) |
NO (1) | NO20004121L (en) |
NZ (1) | NZ506251A (en) |
PL (1) | PL342843A1 (en) |
RU (1) | RU2214405C2 (en) |
SK (1) | SK11892000A3 (en) |
TR (1) | TR200002427T2 (en) |
WO (1) | WO1999042456A2 (en) |
ZA (1) | ZA991301B (en) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7671200B2 (en) | 1999-10-27 | 2010-03-02 | Cytokinetics, Inc. | Quinazolinone KSP inhibitors |
DE10004572A1 (en) | 2000-02-02 | 2001-08-09 | Boehringer Ingelheim Pharma | New positive allosteric AMPA receptor modulators (PAARM), processes for their production and their use as medicines |
FR2812291B1 (en) * | 2000-07-28 | 2002-12-13 | Adir | NOVEL BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
CN1314351A (en) * | 2001-03-22 | 2001-09-26 | 刘志红 | Process for synthesizing quinazolone and quinazolone compound with anti-cancer function |
TWI232863B (en) * | 2001-06-11 | 2005-05-21 | Akzo Nobel Nv | Benzoxazepine derivatives |
AU2002320841B2 (en) | 2001-06-14 | 2008-02-28 | Merck Sharp & Dohme B.V. | (Pyrido/thieno)-[f]-oxazepin-5-one derivatives as positive modulators of the AMPA receptor |
CA2458388A1 (en) | 2001-10-10 | 2003-04-17 | Neurosearch A/S | Novel benzothiazine derivatives, their preparation and use |
US7799913B2 (en) * | 2001-11-26 | 2010-09-21 | Cortex Pharmaceuticals, Inc. | Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
FR2833955B1 (en) | 2001-12-21 | 2004-01-30 | Servier Lab | NOVEL BENZOTHIAZINE AND BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
FR2833950B1 (en) * | 2001-12-21 | 2005-12-16 | Servier Lab | NOVEL BENZOTHIAZINE AND BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
FR2833956B1 (en) | 2001-12-21 | 2004-01-30 | Servier Lab | NOVEL BENZOTHIAZINE AND BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
FR2854634B1 (en) | 2003-05-05 | 2005-07-08 | Servier Lab | NOVEL THIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
FR2856065B1 (en) * | 2003-06-13 | 2005-08-19 | Servier Lab | NOVEL BENZOTHIAZINE AND BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
FR2856064B1 (en) * | 2003-06-13 | 2005-08-19 | Servier Lab | NOVEL BENZOTHIAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
RU2006102869A (en) | 2003-07-02 | 2007-08-10 | Ф.Хоффманн-Ля Рош Аг (Ch) | Arylamino-substituted quinazolinone compounds |
AU2004270161A1 (en) | 2003-08-28 | 2005-03-17 | Nicox S.A. | Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
US7244843B2 (en) | 2003-10-07 | 2007-07-17 | Bristol-Myers Squibb Company | Modulators of serotonin receptors |
FR2865474B1 (en) * | 2004-01-26 | 2008-06-13 | Servier Lab | NOVEL FLUORINATED BENZOTHIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
FR2877338B1 (en) | 2004-11-03 | 2007-01-26 | Servier Lab | NOVEL BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
FR2877342B1 (en) * | 2004-11-03 | 2007-01-26 | Servier Lab | NOVEL BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
FR2879201B1 (en) * | 2004-12-10 | 2007-02-16 | Servier Lab | NOVEL BENZOTHIAZINE AND BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
DE602006004964D1 (en) | 2005-02-10 | 2009-03-12 | Bristol Myers Squibb Co | DIHYDROCHINAZOLINONE AS 5HT MODULATORS |
JP2008531579A (en) | 2005-02-24 | 2008-08-14 | ニトロメッド インコーポレーティッド | Nitric oxide enhanced diuretic compounds, compositions and methods of use |
GB0507298D0 (en) * | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
TW200800959A (en) | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
ES2374995T3 (en) | 2007-01-03 | 2012-02-23 | Les Laboratoires Servier | COMPOSITE OF [1,2,3] -BENZOTRIAZINONE 3-REPLACED TO IMPROVE GLUTAMATERGIC SYNAPTIC RESPONSES. |
TW200901974A (en) | 2007-01-16 | 2009-01-16 | Wyeth Corp | Compounds, compositions, and methods of making and using them |
EA200901546A1 (en) | 2007-05-17 | 2010-04-30 | Кортекс Фармасеутикалс, Инк. | DESIGNED AMIDES FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES |
SG163526A1 (en) | 2007-08-10 | 2010-08-30 | Cortex Pharma Inc | Bicyclic amides for enhancing glutamatergic synaptic responses |
US8168632B2 (en) | 2007-08-10 | 2012-05-01 | Cortex Pharmaceuticals, Inc. | Bicyclic amide derivatives for the treatment of respiratory disorders |
FR2933698A1 (en) | 2008-07-09 | 2010-01-15 | Servier Lab | NOVEL CYCLOALKYLATED BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
FR2943342B1 (en) | 2009-03-20 | 2011-03-04 | Servier Lab | NOVEL BENZOTHIADIAZEPINES DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
SI2464645T1 (en) | 2009-07-27 | 2017-10-30 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
FR2955107B1 (en) | 2010-01-08 | 2012-03-02 | Servier Lab | NOVEL THIOCHROMAN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
FR2955106B1 (en) | 2010-01-08 | 2011-12-23 | Servier Lab | NOVEL CYCLOPROPYLATED BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
CN102958919A (en) * | 2010-07-02 | 2013-03-06 | 霍夫曼-拉罗奇有限公司 | Novel tetrahydroquinoline derivatives |
CN103096977B (en) | 2010-07-02 | 2017-02-15 | 吉利德科学公司 | Fused heterocyclic compounds as ion channel modulators |
FR2964969B1 (en) * | 2010-09-16 | 2012-08-24 | Servier Lab | NOVEL DIHYDROBENZOXATHIAZEPINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
IT1402905B1 (en) * | 2010-11-29 | 2013-09-27 | Univ Degli Studi Modena E Reggio Emilia | DERIVATIVES OF 1,2,4-BENZOTIADIAZIN 1,1-DIOXIDE, THEIR PREPARATION AND THEIR USE AS ALLOSTERIC MODULATORS OF THE AMPA RECEPTOR. |
CN103649056B (en) | 2011-05-10 | 2016-04-27 | 吉利德科学公司 | As the condensed heterocyclic compouds of ion channel modulators |
TW201837023A (en) | 2011-07-01 | 2018-10-16 | 美商基利科學股份有限公司 | Fused heterocyclic compounds as ion channel modulators |
NO3175985T3 (en) | 2011-07-01 | 2018-04-28 | ||
CN102977054A (en) * | 2012-12-12 | 2013-03-20 | 中国药科大学 | Application of selective alpha2A receptor stimulant in treating alzheimer disease |
SG11201509057UA (en) | 2013-05-30 | 2015-12-30 | Actelion Pharmaceuticals Ltd | Cxcr7 receptor modulators |
JO3316B1 (en) | 2013-05-30 | 2019-03-13 | Lilly Co Eli | 3,4-dihydroisoquinolin-2(1h)-yl compounds |
CN103275016B (en) * | 2013-06-04 | 2015-03-11 | 温州医科大学附属第二医院 | Synthetic method of 2-subsituted quinazoline compounds |
BR112015031249A2 (en) | 2013-06-13 | 2017-07-25 | Veroscience Llc | treatment method, method for treating a metabolic disorder or a key element thereof, method for normalizing a daily dopamine release rate in the sumn, method for stimulating dopamine release from dopaminergic neurons in an individual's sumn and pharmaceutical composition |
CN103319381B (en) * | 2013-06-14 | 2014-08-27 | 湖州康企药业有限公司 | Preparation method of high-purity fine sulfanilamide |
CN103772296B (en) * | 2013-12-19 | 2015-06-17 | 安徽师范大学 | Synthesis method for quinazoline derivative |
EP3227263B1 (en) | 2014-12-01 | 2019-04-10 | Idorsia Pharmaceuticals Ltd | Cxcr7 receptor modulators |
CN105294599B (en) * | 2015-09-17 | 2017-09-22 | 三峡大学 | A kind of diazthines compound and its asymmetric synthetic method |
CN106946920A (en) * | 2017-04-05 | 2017-07-14 | 泰力特医药(湖北)有限公司 | A kind of preparation method of 4 amino phenyl boronic acid derivative |
WO2020253862A1 (en) * | 2019-06-21 | 2020-12-24 | 上海翰森生物医药科技有限公司 | Nitrogen-containing aryl phosphorus oxide derivative, preparation method therefor and use thereof |
RU2726456C1 (en) * | 2019-10-02 | 2020-07-14 | Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") | Hepatitis b virus (hbv) inhibitor |
CN111100042B (en) * | 2019-11-18 | 2022-05-31 | 苏州诚和医药化学有限公司 | Preparation method of 2-methoxy-5-sulfonamide benzoic acid |
CN111018750B (en) * | 2019-12-19 | 2022-05-27 | 苏州诚和医药化学有限公司 | Novel preparation method of 2, 3-dimethoxy-5-sulfamide benzoic acid |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL296964A (en) * | ||||
US3275625A (en) * | 1966-09-27 | Derivatives of | ||
FR1217929A (en) * | 1958-03-03 | 1960-05-06 | Ciba Geigy | Process for the preparation of 6-chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide and its salts |
GB863474A (en) * | 1958-08-13 | 1961-03-22 | Knud Abildgaard | Benzothiadiazine derivatives and their preparation |
DE1125938B (en) * | 1960-02-12 | 1962-03-22 | Thomae Gmbh Dr K | Process for the preparation of 7-sulfamyl-3, 4-dihydro-1, 2, 4-benzothiadiazine-1, 1-dioxydes |
GB946864A (en) * | 1960-05-06 | 1964-01-15 | Knud Abildgaard | Method for the production of 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxides |
US3419552A (en) * | 1961-04-12 | 1968-12-31 | Lilly Co Eli | Preparation of substituted dihydrobenzothiadiazine-1,1-dioxides |
CH475269A (en) * | 1962-04-19 | 1969-07-15 | Hans Voigt Chem Pharm Fabrik D | Process for the preparation of 7-sulfonamido-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxydes |
US3351595A (en) * | 1962-12-07 | 1967-11-07 | Ciba Geigy Corp | Derivatives of 3, 4-dihydro-2h-1, 2, 4-benzothiadiazine-1, 1-dioxide |
US3311620A (en) * | 1963-05-31 | 1967-03-28 | Stanley C Bell | Fused ring benzothiadiazines |
US3277086A (en) * | 1964-07-07 | 1966-10-04 | American Home Prod | 1, 2, 4-benzothiadiazine 1, 1-dioxides having a heterocyclic ring fused to the "b" face thereof |
US4184039A (en) * | 1977-12-01 | 1980-01-15 | Paul Finkelstein | Benzothiadiazine 1, 1-dioxides |
AU3957093A (en) * | 1992-04-15 | 1993-11-18 | Rhone-Poulenc Rorer S.A. | 3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxyl ic acid derivatives, preparation thereof and drugs containing same |
US5488049A (en) * | 1993-12-10 | 1996-01-30 | Fidia - Georgetown Institute For The Neuro-Sciences | Method of treating learning and memory disorders using benzothiadiazide derivatives as nootropic agents |
FR2722502B1 (en) * | 1994-07-12 | 1996-08-23 | Adir | NOVEL BENZOTHIADIAZINE DERIVATIVE, ITS PREPARATION METHOD AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
NZ331549A (en) * | 1996-01-29 | 2000-09-29 | Univ California | Compounds useful in treating sexual dysfunction |
AU4345297A (en) * | 1996-09-17 | 1998-04-14 | Regents Of The University Of California, The | Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor |
-
1999
- 1999-02-18 RU RU2000121882/04A patent/RU2214405C2/en not_active IP Right Cessation
- 1999-02-18 WO PCT/DK1999/000070 patent/WO1999042456A2/en not_active Application Discontinuation
- 1999-02-18 ZA ZA9901301A patent/ZA991301B/en unknown
- 1999-02-18 EE EEP200000468A patent/EE200000468A/en unknown
- 1999-02-18 AU AU25123/99A patent/AU751384B2/en not_active Ceased
- 1999-02-18 CN CN99804196A patent/CN1293665A/en active Pending
- 1999-02-18 SK SK1189-2000A patent/SK11892000A3/en unknown
- 1999-02-18 HU HU0101280A patent/HUP0101280A3/en unknown
- 1999-02-18 IL IL13772099A patent/IL137720A0/en unknown
- 1999-02-18 JP JP2000532408A patent/JP2002504481A/en not_active Withdrawn
- 1999-02-18 NZ NZ506251A patent/NZ506251A/en unknown
- 1999-02-18 EP EP99904730A patent/EP1071426A2/en not_active Withdrawn
- 1999-02-18 PL PL99342843A patent/PL342843A1/en unknown
- 1999-02-18 TR TR2000/02427T patent/TR200002427T2/en unknown
- 1999-02-18 CA CA002320354A patent/CA2320354A1/en not_active Abandoned
-
2000
- 2000-08-04 IS IS5581A patent/IS5581A/en unknown
- 2000-08-17 NO NO20004121A patent/NO20004121L/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2214405C2 (en) | 2003-10-20 |
NO20004121D0 (en) | 2000-08-17 |
AU751384B2 (en) | 2002-08-15 |
IL137720A0 (en) | 2001-10-31 |
SK11892000A3 (en) | 2001-02-12 |
CN1293665A (en) | 2001-05-02 |
EP1071426A2 (en) | 2001-01-31 |
HUP0101280A2 (en) | 2001-10-28 |
CA2320354A1 (en) | 1999-08-26 |
ZA991301B (en) | 1999-09-13 |
NO20004121L (en) | 2000-10-17 |
EE200000468A (en) | 2002-04-15 |
TR200002427T2 (en) | 2001-01-22 |
PL342843A1 (en) | 2001-07-16 |
AU2512399A (en) | 1999-09-06 |
HUP0101280A3 (en) | 2003-02-28 |
WO1999042456A3 (en) | 1999-10-07 |
WO1999042456A2 (en) | 1999-08-26 |
IS5581A (en) | 2000-08-04 |
JP2002504481A (en) | 2002-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ506251A (en) | Benzothiadiazine and benzothiadiazepine derivatives and their use as positive AMPA receptor modulators | |
NO994452D0 (en) | Substituted 4-arylmethylene-2-imino-2,3-dihydrotiazoles and derivatives, and their pharmaceutical use | |
HUP9603298A2 (en) | Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation, pharmaceutical compositions containing the same and their use | |
HUP9902471A2 (en) | Piperazine and piperidine compounds, process for their preparation and pharmaceutical compositions containing the same | |
HUP0102187A2 (en) | Azolo triazines and pyrimidines, pharmaceutical compositions containing them and use of the compounds | |
UA48937C2 (en) | Imidasolidins substituted by heterocycle, method for synthesis and pharmaceutical composition containing these substances | |
RU2002125860A (en) | NEW CYCLIC AMIDE DERIVATIVES | |
DE69819891D1 (en) | SPIRO CHINUCLIDINE DERIVATIVES, THEIR PRODUCTION AND USE | |
NZ533666A (en) | Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands | |
HUP0002300A2 (en) | Quinoline-4-carboxamide derivatives, process for producing them, pharmaceutical compositions containing them and their use | |
HK1032234A1 (en) | Azaring-ether derivatives and their use as nicotinic ach receptor modulators. | |
TW429255B (en) | Pyrazine compounds having treatment of central nervous system diseases and disorders | |
BG106080A (en) | Cyclothiocarbamate derivatives as progesterone receptor modulators | |
IL93480A0 (en) | Substituted oxime ethers and fungicides containing same | |
DE69119282D1 (en) | Aminobenzene compounds, manufacture and use | |
HUP0102832A2 (en) | Herbicidal substituted 2,4-diamino-1,3,5-triazine derivatives, preparation and use thereof | |
ES474896A1 (en) | Disubstituted piperazines | |
PL328224A1 (en) | Novel derivatives of 2,3-benzodiazepin, yheir production and use as medicines | |
MXPA94001822A (en) | Acyloxyhexanoic acid derivative. | |
IE780262L (en) | Carbocyclic fused thiophen-2-oxaminic acid derivatives | |
ES502073A0 (en) | METHOD OF PRODUCING ANTI-HYPERTENSIVE BEDS | |
MX9800122A (en) | 1,3-oxazin-4-one derivatives as herbicides. | |
EP0798304A4 (en) | Remedies for thrombocytopenia | |
IE782466L (en) | Iminobridged benzocycloheptapyridines | |
HUP0400834A2 (en) | Novel indole derivatives and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) |